Literature DB >> 2552222

The adrenergic system in lymphocytes from children with cystic fibrosis.

A Schuster1, A Elsen, M Griese, G Kusenbach, D Reinhardt.   

Abstract

Several in vivo and in vitro studies have suggested that children suffering from cystic fibrosis (CF) might have a general defect of beta-adrenoceptors on the cell surface which might account for an unbalanced secretory process. In order to investigate if this view holds true, we determined the beta-adrenoceptor density and affinity on lymphocytes by means of radioligand studies using 125-iodo-cyano-pindolol (125-ICYP) in 20 children with CF. Cyclic AMP (cAMP) response was also investigated after specific beta-adrenoceptor stimulation with isoprenaline (IPN) and after direct stimulation of the adenylate cyclase with forskolin in lymphocytes. Children with CF and controls have identical numbers and affinities of beta-adrenoceptors on lymphocytes. The cyclic AMP response was identical in CF- and in age-matched control children regardless whether adenylate cyclase was stimulated directly or via beta-adrenoceptors. In conclusion, the data support the view that no general adrenoceptor or adenylate cyclase defect exists in CF. As several studies have found abnormal reactions to adrenergic stimuli in CF patients, we presume that there is a defect beyond the level of adrenergic receptors and cAMP which remains to be identified.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552222     DOI: 10.1007/BF01725195

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  28 in total

1.  Decreased adenosine 3':5'-monophosphate response to isoproterenol in cystic fibrosis leukocytes.

Authors:  P B Davis; M Braunstein; C Jay
Journal:  Pediatr Res       Date:  1978-06       Impact factor: 3.756

2.  Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids.

Authors:  A L Steiner; A S Pagliara; L R Chase; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

3.  A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Abnormal adrenergic and cholinergic sensitivity in cystic fibrosis.

Authors:  P B Davis; J R Shelhamer; M Kaliner
Journal:  N Engl J Med       Date:  1980-06-26       Impact factor: 91.245

5.  Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting.

Authors:  H A Feldman
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

6.  Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.

Authors:  L T Williams; R Snyderman; R J Lefkowitz
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

7.  Defective beta adrenergic response of cystic fibrosis sweat glands in vivo and in vitro.

Authors:  K Sato; F Sato
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

8.  The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis.

Authors:  G G Shapiro; J Bamman; P Kanarek; C W Bierman
Journal:  Pediatrics       Date:  1976-11       Impact factor: 7.124

9.  Abnormal levels of 3':5'-cyclic AMP in isoproterenol-stimulated fibroblasts from patients with cystic fibrosis.

Authors:  M Buchwald
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

10.  Different mechanisms underlying reduced beta 2-adrenoceptor responsiveness in lymphocytes from neonates and old subjects.

Authors:  N O'Hara; A E Daul; R Fesel; U Siekmann; O E Brodde
Journal:  Mech Ageing Dev       Date:  1985 Jul-Aug       Impact factor: 5.432

View more
  1 in total

1.  Influence of short- and long-term inhalation of salbutamol on lung function and beta 2-adrenoceptors of mononuclear blood cells in asthmatic children.

Authors:  A Schuster; R Kozlik; D Reinhardt
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.